Professional Documents
Culture Documents
TO
PETCARE
Submitted by
L.RAGHAVENDRA NAIDU
By
CERTIFICATE
This is to certify that project report entitled “A STUDY ON MARKET
ANALYSIS ON VETERNARY PRODUCTS “ WITH REFERENCE TO
PETCARE IN
-HYDERABAD ” submitted by L.RAGHAVENDRA NAIDU(Reg.
No.0900101035) to the Department ofBusiness Management,
VIKRAMA SIMHAPURI UNIVERSITY,NELLORE in partial
fulfillment of requirements for the award of degree of MBA is a
bonafide record of work carried out under my supervision. The
contents of this project, in full or in part have not been submitted in any
form to any other institute or university for the award of any degree or
diploma.
Mrs.J.VIJETHA Dr.
Suja.S.Nair
Internal Guide, Incharge Head
of Department,
Dept. of Business Management, Dept. of Business
Management,
VSU, Nellore. VSU, Nellore.
DECLARATION
Place:
Date: L.RAGHAVENDRA
NAIDU
ABSTRACT
The Indian pharmaceutical market is a very fragmented market and does not
recognize product patent. Hence brand differentiation is very difficult in a
market. Where there are over 50 brands for every molecule. Thus the
relationship between the medical representative (The main medium of
promotion) and the Doctor is the key driver for sales.
Veterinary products are not consumer oriented goods. So, without Doctor
Suggestions customer will not prescribe.
For this data gathering I used to interact with doctors to know the present boom
for the products between the company product and competitor products. And
second tool is questionnaires survey questions should be categorized into three
types.
2. Key attitude: Satisfaction with key areas of business, e.g. Sales, Marketing,
Operations etc.
3. Drill Down: Satisfaction with issues that are unique to each attitude, and
upon which action may be taken to directly remedy that key attributes issues.
For enhance the growth of products company should develop the relationship
with Doctors for this develop marketing representatives play a key role because
M.R. are main Media promotion. The company will fallow these strategies it
will be the benchmark for competitors.
ACKNOWLEDGMENTS
CONTENTS PAGE
NO:
List of Tables:
I
List of Figures: II
CHAPTER-1
Introduction
1
CHAPTER-2
Company/Organization profile
16/33
CHAPTER-3
CHAPTER-4
Findings
67
Recommendations
68
Conclusion
69
CHAPTER-5
Bibliography
72
CHAPTER-6
Appendix A-Organization structure
75
Appendix B-Druggist Questionnaire
76
Appendix C-Personal interview with doctors
77
LIST OF TABLES
S.NO FIGURES PAGE NO:
LIST OF FIGURES
ii